Bone responses to rough titanium implants coated with biomimetic Ca-P in rabbit tibia

Current research on implant integration focuses on improving bone-implant interactions. Titanium surfaces are widely used due to their biocompatibility. However, surface modifications can influence osseointegration rates. Some studies suggest that calcium phosphate coatings may enhance bone growth. Others have found no significant differences between coated and uncoated surfaces. The medullary region of bone shows distinct healing patterns compared to the cortical region. Surface roughness can affect how bone cells respond to implants. No prior work had resolved whether biomimetic Ca-P coatings improve bone formation in cortical areas. This gap motivated the current investigation into the effects of BDCaP coatings on bone integration.

This study aimed to compare bone responses to BDCaP-coated and uncoated titanium implants in rabbit tibia. The researchers wanted to determine if the coating improves bone ingrowth in both cortical and medullary regions. They focused on a rabbit model due to its relevance to human bone healing. The implants were placed in tibia to simulate clinical conditions. Bone-implant contact and bone ingrowth were the primary outcomes. The study evaluated these outcomes at 2, 4, and 8 weeks post-implantation. The researchers proposed that BDCaP might enhance early bone formation. They sought to clarify whether the coating benefits long-term integration.

The study used 31 titanium implants placed in the tibia of 15 rabbits. Sixteen implants were coated with BDCaP, and 15 were rough but uncoated. The implants were inserted bilaterally to allow within-subject comparisons. After 2, 4, and 8 weeks, the tibiae were retrieved for analysis. Histological techniques were used to assess bone-implant contact. Quantitative histomorphometry measured bone ingrowth in threads. The medullary and cortical regions were analyzed separately. The researchers compared coated and uncoated implants at each time point.

At 2 weeks, BDCaP-coated implants showed more bone ingrowth in the medullary region than uncoated ones. The difference was 31.43% for coated and 24.38% for uncoated implants. No significant differences were found in the cortical region at any time point. Bone-implant contact remained similar between groups after 4 and 8 weeks. Histological evaluation showed no enhanced bone formation with the coating. The researchers noted that the coating did not improve cortical bone integration. The results suggest that BDCaP may only benefit early medullary bone growth. The findings indicate that the coating has limited effects on long-term outcomes.

The study found that BDCaP coatings may enhance early bone ingrowth in the medullary region. However, the coating did not improve bone-implant contact in the cortical region. The researchers proposed that the coating may not benefit long-term integration. The results suggest that BDCaP may have limited clinical value in cortical bone. The findings do not support the use of BDCaP for enhancing cortical osseointegration. The study highlights the importance of evaluating both bone regions separately. The researchers noted that the coating may not be essential for cortical healing. The results align with prior findings on the limited effects of Ca-P coatings in cortical bone.